Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. SpringWorks Therapeutics Inc shares valued at $1,084,592 were sold by Edris Badreddin on Mar 03 ’25. At $54.23 per share, Edris Badreddin sold 20,000 shares. The insider’s holdings dropped to 169,712 shares worth approximately $7.97 million following the completion of this transaction.
Also, Islam Saqib sold 49,000 shares, netting a total of over 2,657,656 in proceeds. Following the sale of shares at $54.24 each, the insider now holds 954,869 shares.
Before that, Islam Saqib had sold 29,328 shares from its account. In a trade valued at $1,768,401, the Chief Executive Officer traded SpringWorks Therapeutics Inc shares for $60.30 each. Upon closing the transaction, the insider’s holdings decreased to 29,328 shares, worth approximately $48.6 million.
As published in their initiating research note from Evercore ISI on November 20, 2024, SpringWorks Therapeutics Inc [SWTX] has been an Outperform and the price target has been revised to $60. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early February. As of December 01, 2022, BofA Securities has initiated its “Buy” rating for SWTX. Earlier on January 19, 2021, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for SWTX stock.
Analyzing SWTX Stock Performance
On last trading session,, SpringWorks Therapeutics Inc [NASDAQ: SWTX] rose 0.02% to $46.97. The stock’s lowest price that day was $46.95, but it reached a high of $46.98 in the same session. During the last five days, there has been a surge of approximately 0.23%. Over the course of the year, SpringWorks Therapeutics Inc shares have jumped approximately 30.04%. Shares of the company reached a 52-week high of $62.00 on 02/20/25 and a 52-week low of $31.95 on 01/15/25.
Support And Resistance Levels for SpringWorks Therapeutics Inc (SWTX)
According to the 24-hour chart, there is a support level at 46.95, which, if violated, would cause prices to drop to 46.94. In the upper region, resistance lies at 46.98. The next price resistance is at 47.00. RSI (Relative Strength Index) is 63.44 on the 14-day chart, showing neutral technical sentiment.
Is SpringWorks Therapeutics Inc subject to short interest?
Stocks of SpringWorks Therapeutics Inc saw a sharp rise in short interest on 2025-05-30 jumping by 0.98 million shares to 6.24 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 5.27 million shares. A jump of 15.62% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.18 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.18.
Which companies own the most shares of SpringWorks Therapeutics Inc (SWTX)?
In terms of SpringWorks Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 62.5 in the next 12 months, up nearly 33.09% from the previous closing price of $46.96. Analysts anticipate SpringWorks Therapeutics Inc stock to reach 78 by 2025, with the lowest price target being 47. In spite of this, 3 analysts ranked SpringWorks Therapeutics Inc stock as Buy at the end of 2025. On October 29, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $73.
